UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2014-08, Vol.66 (8), p.2091-2102

2014

Volltextzugriff (PDF)

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study

Annals of the rheumatic diseases, 2016-07, Vol.75 (7), p.1328-1335

2016

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis

Modern rheumatology, 2013-07, Vol.23 (4), p.623-633

2013

Volltextzugriff (PDF)

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

Modern rheumatology, 2012-09, Vol.22 (5), p.720-726

2012

Volltextzugriff (PDF)

Etanercept in the longterm treatment of patients with ankylosing spondylitis

Journal of rheumatology, 2009-06, Vol.36 (6), p.1256-1264

2009

Volltextzugriff (PDF)

Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials

Modern rheumatology, 2015-03, Vol.25 (2), p.173-186

2015

Volltextzugriff (PDF)

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

Modern rheumatology, 2011-12, Vol.21 (6), p.572-578

2011

Volltextzugriff (PDF)

Variability in Antinuclear Antibody Testing to Assess Patient Eligibility for Clinical Trials of Novel Treatments for Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2019-09, Vol.71 (9), p.1534-1538

2019

Volltextzugriff (PDF)

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

Modern rheumatology, 2011-12, Vol.21 (6), p.572-578

2011

Volltextzugriff (PDF)

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

The Lancet (British edition), 2004-02, Vol.363 (9410), p.675-681

2004

Volltextzugriff (PDF)

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

Annals of the rheumatic diseases, 2017-03, Vol.76 (3), p.534-542

2017

Volltextzugriff (PDF)

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis

Clinical and experimental rheumatology, 2011-03, Vol.29 (2), p.238

2011

Volltextzugriff (PDF)

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial

Arthritis and rheumatism, 2006-04, Vol.54 (4), p.1063-1074

2006

Volltextzugriff (PDF)

Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis

Dermatology (Basel), 2009-01, Vol.219 (3), p.239-249

2009

Volltextzugriff (PDF)

Unaltered Etanercept Pharmacokinetics With Concurrent Methotrexate in Patients With Rheumatoid Arthritis

Journal of clinical pharmacology, 2004-11, Vol.44 (11), p.1235-1243

2004

Volltextzugriff (PDF)

Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications

Journal of drugs in dermatology, 2011-03, Vol.10 (3), p.289

2011

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis

Modern rheumatology, 2013-07, Vol.23 (4), p.623-633

2013

Volltextzugriff (PDF)

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

Modern rheumatology, 2012-09, Vol.22 (5), p.720-726

2012

Volltextzugriff (PDF)

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ETANERCEPT 25 TWICE WEEKLY IN PATIENTS WITH SEVERE PERSISTENT ASTHMA

Chest, 2007-10, Vol.132 (4), p.436B-436B

2007

Volltextzugriff (PDF)

Long-term, continuous dosing of etanercept in patients with plaque psoriasis

Expert Review of Dermatology, 2011-08, Vol.6 (4), p.361-373

2011

Volltextzugriff (PDF)

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Commentary

The Lancet (British edition), 2004, Vol.363 (9410), p.675-671

2004

Volltextzugriff (PDF)

A food interaction study of bromfenac, naproxen sodium, and placebo in cesarean section patients

Primary care update for Ob/Gyns, 1998-07, Vol.5 (4), p.195-195

1998

Volltextzugriff (PDF)

The dependence of the duodenal intercontractile interval on the animal model

Wajdula, Joseph Stanley

1987

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(25)
Dissertationen
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Etanercept
(17)
Female
(15)
Male
(15)
Rheumatology
(14)
Treatment Outcome
(12)
Antirheumatic Agents - Therapeutic Use
(10)
Immunoglobulin G - Therapeutic Use
(9)
Receptors, Tumor Necrosis Factor - Therapeutic Use
(9)
Adult
(8)
Double-Blind Method
(8)
Arthritis, Rheumatoid - Drug Therapy
(7)
Middle Aged
(7)
Antirheumatic Agents - Adverse Effects
(6)
Biological And Medical Sciences
(6)
Clinical Trials
(6)
Medical Sciences
(6)
Severity Of Illness Index
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study

A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

Etanercept in the longterm treatment of patients with ankylosing spondylitis

Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

Variability in Antinuclear Antibody Testing to Assess Patient Eligibility for Clinical Trials of Novel Treatments for Systemic Lupus Erythematosus

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial

Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis

Unaltered Etanercept Pharmacokinetics With Concurrent Methotrexate in Patients With Rheumatoid Arthritis

Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications

A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ETANERCEPT 25 TWICE WEEKLY IN PATIENTS WITH SEVERE PERSISTENT ASTHMA

Long-term, continuous dosing of etanercept in patients with plaque psoriasis

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Commentary

A food interaction study of bromfenac, naproxen sodium, and placebo in cesarean section patients

The dependence of the duodenal intercontractile interval on the animal model

Suchergebnisse filtern